Establishing an ad hoc COVID-19 mortality surveillance during the first epidemic wave in Belgium, 1 March to 21 June 2020.


Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
12 2021
Historique:
entrez: 3 12 2021
pubmed: 4 12 2021
medline: 15 12 2021
Statut: ppublish

Résumé

BackgroundCOVID-19-related mortality in Belgium has drawn attention for two reasons: its high level, and a good completeness in reporting of deaths. An ad hoc surveillance was established to register COVID-19 death numbers in hospitals, long-term care facilities (LTCF) and the community. Belgium adopted broad inclusion criteria for the COVID-19 death notifications, also including possible cases, resulting in a robust correlation between COVID-19 and all-cause mortality.AimTo document and assess the COVID-19 mortality surveillance in Belgium.MethodsWe described the content and data flows of the registration and we assessed the situation as of 21 June 2020, 103 days after the first death attributable to COVID-19 in Belgium. We calculated the participation rate, the notification delay, the percentage of error detected, and the results of additional investigations.ResultsThe participation rate was 100% for hospitals and 83% for nursing homes. Of all deaths, 85% were recorded within 2 calendar days: 11% within the same day, 41% after 1 day and 33% after 2 days, with a quicker notification in hospitals than in LTCF. Corrections of detected errors reduced the death toll by 5%.ConclusionBelgium implemented a rather complete surveillance of COVID-19 mortality, on account of a rapid investment of the hospitals and LTCF. LTCF could build on past experience of previous surveys and surveillance activities. The adoption of an extended definition of 'COVID-19-related deaths' in a context of limited testing capacity has provided timely information about the severity of the epidemic.

Identifiants

pubmed: 34857066
doi: 10.2807/1560-7917.ES.2021.26.48.2001402
pmc: PMC8641068
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Arch Public Health. 2021 Oct 27;79(1):188
pubmed: 34706768
Health Syst Transit. 2010;12(5):1-266, xxv
pubmed: 21224177
Arch Public Health. 2020 Nov 13;78(1):117
pubmed: 33292536
Radiology. 2020 Aug;296(2):E32-E40
pubmed: 32101510
Eur Radiol. 2020 Sep;30(9):4903-4909
pubmed: 32314058
Arch Public Health. 2020 Nov 18;78(1):121
pubmed: 33292566

Auteurs

Françoise Renard (F)

Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium.

Aline Scohy (A)

Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium.

Johan Van der Heyden (J)

Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium.

Ilse Peeters (I)

Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium.

Sara Dequeker (S)

Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium.

Eline Vandael (E)

Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium.

Nina Van Goethem (N)

Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium.

Dominique Dubourg (D)

Agence pour une Vie de Qualité (AViQ), Charleroi, Belgium.

Louise De Viron (L)

Commission Communautaire Commune de la Région de Bruxelles-Capitale (COCOM), Brussels, Belgium.

Anne Kongs (A)

Agentschap Zorg en Gezondheid (AZG), Vlaanderen, Brussels, Belgium.

Naïma Hammami (N)

Agentschap Zorg en Gezondheid (AZG), Vlaanderen, Brussels, Belgium.

Brecht Devleesschauwer (B)

Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium.
Department of Veterinary Public Health and Food Safety, Ghent University, Merelbeke, Belgium.

André Sasse (A)

Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium.

Javiera Rebolledo Gonzalez (J)

Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium.

Natalia Bustos Sierra (N)

Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH